| Increased peripheral blood inflammatory cytokine levels in amyotrophic lateral sclerosis: a meta-analysis study Y Hu, C Cao, XY Qin, Y Yu, J Yuan, Y Zhao, Y Cheng Scientific Reports 7 (1), 9094, 2017 | 154 | 2017 |
| Cerebrospinal fluid and blood cytokines as biomarkers for multiple sclerosis: a systematic review and meta-analysis of 226 studies with 13,526 multiple sclerosis patients Z Bai, D Chen, L Wang, Y Zhao, T Liu, Y Yu, T Yan, Y Cheng Frontiers in Neuroscience 13, 1026, 2019 | 85 | 2019 |
| Treatment with humanized selective CD19CAR-T cells shows efficacy in highly treated B-ALL patients who have relapsed after receiving murine-based CD19CAR-T therapies Y Zhao, Z Liu, X Wang, H Wu, J Zhang, J Yang, F Zhang, L Liu, J Long, ... Clinical Cancer Research 25 (18), 5595-5607, 2019 | 44 | 2019 |
| Acute activation of β2-adrenergic receptor regulates focal adhesions through βArrestin2-and p115RhoGEF protein-mediated activation of RhoA X Ma, Y Zhao, Y Daaka, Z Nie Journal of Biological Chemistry 287 (23), 18925-18936, 2012 | 41 | 2012 |
| A recombinant cell-permeable p53 fusion protein is selectively stabilized under hypoxia and inhibits tumor cell growth Z Yu, J Wu, S Wu, P Jia, Y Tong, X Wu, Y Wang Cancer letters 279 (1), 101-107, 2009 | 27 | 2009 |
| Detection of residual toxin in tissues of ricin-poisoned mice by sandwich enzyme-linked immunosorbent assay and immunoprecipitation J Men, L Lang, C Wang, J Wu, Y Zhao, PY Jia, W Wei, Y Wang Analytical biochemistry 401 (2), 211-216, 2010 | 26 | 2010 |
| The Arf GAP AGAP2 interacts with β-arrestin2 and regulates β2-adrenergic receptor recycling and ERK activation Y Wu, Y Zhao, X Ma, Y Zhu, J Patel, Z Nie Biochemical Journal 452 (3), 411-421, 2013 | 21 | 2013 |
| Introduction of hypoxia-targeting p53 fusion protein for the selective therapy of non-small cell lung cancer Y Zhao, S Wu, J Wu, P Jia, S Gao, X Yan, Y Wang Cancer biology & therapy 11 (1), 95-107, 2011 | 17 | 2011 |
| An organophosphorus hapten used in the preparation of monoclonal antibody and as an active immunization vaccine in the detoxication of soman poisoning P Jia, Y Wang, M Yu, J Wu, R Yang, Y Zhao, L Zhou Toxicology letters 187 (1), 45-51, 2009 | 12 | 2009 |
| CaMKIIα signaling is required for the neuroprotective effects of Dl-3-n-butylphthalide in Alzheimer’s disease B Li, L Xu, F Li, Y Li, Y Zhao, H Zhang, M Quan, J Jia Molecular Neurobiology 59 (6), 3370-3381, 2022 | 8 | 2022 |
| Determination of ricin by double antibody sandwich enzyme-linked immunosorbent assay in different samples. LW Lang, YX Wang, CY Wang, Y Zhao, PY Jia, FH Fu Journal of International Pharmaceutical Research 36 (1), 12-16, 2009 | 7 | 2009 |
| 5T4 oncotrophoblast glycoprotein: janus molecule in life and a novel potential target against tumors Y Zhao, Y Wang Cell Mol Immunol 4 (2), 99-104, 2007 | 7 | 2007 |
| Immunochromatography detection of ricin in environmental and biological samples H Li Nano Biomed. Eng 3 (3), 169-173, 2011 | 5 | 2011 |
| Long-term safety and efficacy of CD19 humanized selective CAR-T therapy in B-ALL patients who have previously received murine-based CD19 CAR-T therapy Y Zhao, J Zhang, J Yang, H Wu, Y Chen, N Li, Z Liu, X Wang, W Liu, ... Frontiers in Oncology 12, 884782, 2022 | 4 | 2022 |
| The novel fusion proteins, GnRH-p53 and GnRHIII-p53, expression and their anti-tumor effect P Jia, Y Zhao, S Wu, J Wu, S Gao, Y Tong, Y Wang Plos one 8 (11), e79384, 2013 | 4 | 2013 |
| Therapeutic effects against high-grade glioblastoma mediated by engineered induced neural stem cells combined with GD2-specific CAR-NK W Liu, Y Zhao, Z Liu, G Zhang, H Wu, X Zheng, X Tang, Z Chen Cellular Oncology 46 (6), 1747-1762, 2023 | 3 | 2023 |
| A CH2CH3 hinge region enhances the cytotoxicity of anti-CD5 CAR-T cells targeting T cell acute lymphoblastic leukemia H Wu, Y Yu, Y Zhao, W Liu, Z Liu, G Zhang, Z Chen International Immunopharmacology 124, 110904, 2023 | 3 | 2023 |
| GD2 CAR-T cells in combination with Nivolumab exhibit enhanced antitumor efficacy G Zhang, Y Zhao, Z Liu, W Liu, H Wu, X Wang, Z Chen Translational Oncology 32, 101663, 2023 | 3 | 2023 |
| Case report: Humanized selective CD19CAR-T treatment induces MRD-negative remission in a pediatric B-ALL patient with primary resistance to murine-based CD19CAR-T therapy K Wang, Y Zhao, X Wang, B Wang, M Qin, G Zhu, H Wu, Z Liu, X Zheng, ... Frontiers in Immunology 11, 581116, 2020 | 3 | 2020 |
| Enhanced anti-tumor activity mediated by combination chimeric antigen receptor T cells targeting GD2 and GPC2 in high-risk neuroblastoma H Wu, G Zhang, Z Liu, W Liu, X Wang, Y Zhao Cytotherapy, 2024 | | 2024 |
